Astellas Pharma Inc ALPMF:OTCPK

RT Quote | Exchange | USD
Last | 3:01 PM EDT
17.00quote price arrow up+0.34 (+2.04%)
Volume
400
52 week range
13.50 - 18.00
Loading...
  • Open17.00
  • Day High17.00
  • Day Low17.00
  • Prev Close16.66
  • 52 Week High18.00
  • 52 Week High Date06/22/21
  • 52 Week Low13.50
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap31,880.94M
  • Shares Out1,852.85M
  • 10 Day Average Volume575
  • Dividend0.38
  • Dividend Yield2.26%
  • Beta-
  • YTD % Change11.26

KEY STATS

  • Open17.00
  • Day High17.00
  • Day Low17.00
  • Prev Close16.66
  • 52 Week High18.00
  • 52 Week High Date06/22/21
  • 52 Week Low13.50
  • 52 Week Low Date11/02/20
  • Market Cap31,880.94M
  • Shares Out1,852.85M
  • 10 Day Average Volume575
  • Dividend0.38
  • Dividend Yield2.26%
  • Beta-
  • YTD % Change11.26

RATIOS/PROFITABILITY

  • EPS (TTM)0.49
  • P/E (TTM)34.76
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/30/2021
  • Div Amount21.00
  • Split Date-
  • Split Factor-

Latest On Astellas Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Yoshihiko Hatanaka
Chairman
Kenji Yasukawa
President
Naoki Okamura
Chief Financial Officer
Address
2-5-1, Nihombashihon-cho
Chuo-ku, TKY
103-8411
Japan